Skip to main content
. 2021 Nov 10;13(22):5614. doi: 10.3390/cancers13225614
HGG High-grade glioma
FUS Focused Ultrasound
BBB Blood-Brain Barrier
US Ultrasound
5-ALA 5-Aminolevulinic Acid
MRI Magnetic Resonance Imaging
TMZ Temozolomide
KPS Karnofsky Performance Status
CT Computed Tomography
RT Radiotherapy
H Hematoma
TND Transient Neurological Deficit
NL New Lesion
NA Not Assessed
IV Intravenous
GBM Glioblastoma
AA Anaplastic Astrocytoma
PFS Progression-Free Survival
OS Overall Survival
DLT Dose Limiting Toxicity
RT Radiotherapy